# Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

> **NCT00900172** · — · COMPLETED · sponsor: **ECOG-ACRIN Cancer Research Group** · enrollment: 180 (actual)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** bevacizumab
- **DRUG:** carboplatin
- **DRUG:** paclitaxel
- **GENETIC:** gene expression analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT00900172
- **Lead sponsor:** ECOG-ACRIN Cancer Research Group
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-15
- **Primary completion:** 2009-04-15
- **Final completion:** 2009-04-15
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2017-05-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00900172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00900172, "Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00900172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*